Key result
Exercise and targeted molecular therapies mitigate age-related cardiac decline by counteracting senescence and mitochondrial dysfunction.
Why the study?
Understanding of cardiac aging is limited despite growing urgency to address age-related cardiac decline and heart failure susceptibility in an expanding elderly population.
Answers are grounded in this paper and cite their sources.
This review synthesizes the molecular mechanisms driving age-related heart failure—such as mitochondrial dysfunction, cellular senescence, and epigenetic/noncoding RNA alterations—and highlights exercise as an experimental platform to identify novel cardioprotective therapeutic targets.
During aging, deterioration in cardiac structure and function leads to increased susceptibility to heart failure. The need for interventions to combat this age-related cardiac decline is becoming increasingly urgent as the elderly population continues to grow. Our understanding of cardiac aging, and aging in general, is limited. However, recent studies of age-related decline and its prevention through interventions like exercise have revealed novel pathological and cardioprotective pathways. In this review, we summarize recent findings concerning the molecular mechanisms of age-related heart failure and highlight exercise as a valuable experimental platform for the discovery of much-needed novel therapeutic targets in this chronic disease.
No takes yet. Share an insight, caveat, or question.
A 2020 study conducted a review in Age-related heart failure and cardiac aging. Exercise and molecular pathway targeting (senolytics, metabolic modulators, epigenetic/ncRNA regulators) was evaluated. Exercise and targeted molecular interventions mitigate age-related cardiac decline by modulating mitochondrial dysfunction, cellular senescence, telomere attrition, and noncoding RNAs.
Synapse has enriched 10 related papers. Consider them for comparative context: